Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
3.440
+0.200 (6.17%)
At close: Nov 20, 2024, 4:00 PM
3.460
+0.020 (0.58%)
After-hours: Nov 20, 2024, 4:53 PM EST
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.14 million as of November 21, 2024. Its market cap has decreased by -74.62% in one year.
Market Cap
1.14M
Enterprise Value
-4.36M
1-Year Change
-74.62%
Ranking
Category
Stock Price
$3.44
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $1.14M, a decrease of -98.31%. That is a compound annual growth rate of -74.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.14M | -24.67% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entero Therapeutics | 1.33M |
| ZyVersa Therapeutics | 1.32M |
| Revelation Biosciences | 1.28M |
| Tenon Medical | 1.25M |
| Catheter Precision | 1.23M |
| Elevai Labs | 1.05M |
| Psyence Biomedical | 876.57K |
| SciSparc | 857.08K |